Bajaj Healthcare Ltd (BAJAJHCARE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002590, "name": "Bajaj Healthcare", "stock_name": "Bajaj Healthcare", "full_name": "Bajaj Healthcare Ltd", "name_url": "stocks-analysis/bajaj-healthcare", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "329.30", "chg": -0.2, "chgp": "-0.06%", "dir": -1, "prev_price": "329.50", "mcapval": "1,111.00 Cr", "mcap": "Micro Cap", "scripcode": 539872, "symbol": "BAJAJHCARE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE411U01027", "curr_date": "Aug 07, 03:30 PM", "curr_time": "07:30 AM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "97.88 k", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bajaj-healthcare-1002590-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Bajaj Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/bajaj-healthcare-ltd-is-rated-sell-4133485", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BajajHealthcare_mojoScore_4133485.png", "date": "2026-08-03 10:10:44", "description": "Bajaj Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 03 August 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Bajaj Healthcare Declines 13.61%: Margin Pressures and Valuation Shifts Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/bajaj-healthcare-declines-1361-margin-pressures-and-valuation-shifts-shape-week-4120518", "imagepath": "", "date": "2026-07-25 13:04:33", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Stock opens strong at Rs.384.80 (+2.90%) despite flat market</p>\n <p><strong>21 Jul:</strong> Quarterly results reveal flat performance; stock drops 3.83%</p>\n <p><strong>22 Jul:</strong> Valuation shifts noted; stock plunges 12.70%</p>\n <p><strong>24 Jul:</strong> Minor recovery to Rs.323.05 (+1.62%) as week closes</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.373.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..." }, { "title": "Bajaj Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/bajaj-healthcare-ltd-is-rated-sell-4117620", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BajajHealthcare_mojoScore_4117620.png", "date": "2026-07-23 10:10:52", "description": "Bajaj Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 July 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Bajaj Healthcare Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/bajaj-healthcare-ltd-valuation-shifts-signal-changing-market-sentiment-4114394", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BajajHealthcare_valuationdot_4114394.png", "date": "2026-07-22 08:01:43", "description": "Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its valuation parameters shift from very attractive to attractive, reflecting a nuanced change in price appeal. Despite a downgrade in its Mojo Grade from Hold to Sell as of 30 June 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more favourable entry point relative to its historical and peer averages. This article analyses the evolving valuation landscape of Bajaj Healthcare and its implications for investors." }, { "title": "Are Bajaj Healthcare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-bajaj-healthcare-ltd-latest-results-good-or-bad-4114076", "imagepath": "", "date": "2026-07-21 19:15:33", "description": "Bajaj Healthcare Ltd's latest financial results for the quarter ended June 2026 reflect a complex operational landscape. The company reported net sales of ₹165.63 crores, marking an 11.28% year-on-year growth, although this growth rate is lower than the previous year's figure of 12.54%. The standalone net profit for the same period was ₹13.89 crores, which shows a year-on-year increase of 15.81%, down from a more robust growth of 65.92% in the prior year.\n\nThe operating profit before depreciation, interest, tax, and other income (PBDIT) stood at ₹28.75 crores, with an operating margin of 17.36%. This margin reflects a modest improvement compared to the previous quarter, indicating some progress in cost management and operational efficiency. However, the year-on-year comparison shows a decline in growth rates for both sales and profit, suggesting that while the company is recovering from prior losses, it fac..." }, { "title": "Bajaj Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/bajaj-healthcare-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4112590", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BajajHealthcare_fintrenddot_4112590.png", "date": "2026-07-21 11:00:16", "description": "Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record quarterly net sales, the company’s overall financial trend has softened, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 June 2026." }, { "title": "Bajaj Healthcare Q1 FY27: Recovery Gains Momentum Despite Profitability Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/bajaj-healthcare-q1-fy27-recovery-gains-momentum-despite-profitability-concerns-4112658", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BajajHealthcare_quaterlyResult_4112658.png", "date": "2026-07-21 09:47:52", "description": "Bajaj Healthcare Ltd., a Thane-based bulk drug manufacturer serving global pharmaceutical markets, reported a mixed performance for Q1 FY27 ending June 2026, with net profit rising to ₹13.89 crores—marking a sequential recovery of 171.54% from the previous quarter's loss of ₹19.41 crores. However, the year-on-year comparison reveals a modest 14.13% increase from ₹12.17 crores in Q1 FY26, whilst the stock has faced significant headwinds, declining 28.85% over the past year to close at ₹369.50 on July 21, 2026, with a market capitalisation of ₹1,243.84 crores." }, { "title": "Bajaj Healthcare Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/bajaj-healthcare-ltd-is-rated-hold-by-marketsmojo-4097222", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BajajHealthcare_mojoScore_4097222.png", "date": "2026-07-12 10:10:37", "description": "Bajaj Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 July 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Bajaj Healthcare Ltd Falls 2.46%: Mixed Technicals and Valuation Shifts Define Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/bajaj-healthcare-ltd-falls-246-mixed-technicals-and-valuation-shifts-define-week-4088688", "imagepath": "", "date": "2026-07-04 14:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Jun:</strong> Week opens at ₹353.45</p>\n <p><strong>30 Jun:</strong> MarketsMOJO upgrades Bajaj Healthcare to Hold on improved technicals and financials</p>\n <p><strong>1 Jul:</strong> Technical momentum shifts to sideways trend amid mixed signals</p>\n <p><strong>2 Jul:</strong> Technical momentum shifts again to mildly bearish; valuation grade upgraded to 'very attractive'</p>\n <p><strong>3 Jul:</strong> Week closes at ₹344.75, down 2.46% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><di..." } ], "total": 309, "sid": "1002590", "stock_news_url": "https://www.marketsmojo.com/news/No announcements on in the last one month-1002590" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Credit Rating", "datetime": "06-Aug-2026", "details": "Revision in Credit Rating", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "27-Jul-2026", "details": "Transcript of Earnings Call for Q1FY27", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "22-Jul-2026", "details": "Intimation for Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bajaj Healthcare Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Bajaj Healthcare Ltd has announced <strong>5:10</strong> stock split, ex-date: 28 Sep 21", "dt": "2021-09-28", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Bajaj Healthcare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 09 Apr 19", "dt": "2019-04-09", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Jul: Stock opens strong at Rs.384.80 (+2.90%) despite flat market

21 Jul: Quarterly results reveal flat performance; stock drops 3.83%

22 Jul: Valuation shifts noted; stock plunges 12.70%

24 Jul: Minor recovery to Rs.323.05 (+1.62%) as week closes

Week Open

Rs.373.95

Week Close

Read full news article

Bajaj Healthcare Ltd is Rated Sell

2026-07-23 10:10:52

Bajaj Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Bajaj Healthcare Ltd Valuation Shifts Signal Changing Market Sentiment

2026-07-22 08:01:43

Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently seen its valuation parameters shift from very attractive to attractive, reflecting a nuanced change in price appeal. Despite a downgrade in its Mojo Grade from Hold to Sell as of 30 June 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more favourable entry point relative to its historical and peer averages. This article analyses the evolving valuation landscape of Bajaj Healthcare and its implications for investors.

Read full news article

Are Bajaj Healthcare Ltd latest results good or bad?

2026-07-21 19:15:33

Bajaj Healthcare Ltd's latest financial results for the quarter ended June 2026 reflect a complex operational landscape. The company reported net sales of ₹165.63 crores, marking an 11.28% year-on-year growth, although this growth rate is lower than the previous year's figure of 12.54%. The standalone net profit for the same period was ₹13.89 crores, which shows a year-on-year increase of 15.81%, down from a more robust growth of 65.92% in the prior year. The operating profit before depreciation, interest, tax, and other income (PBDIT) stood at ₹28.75 crores, with an operating margin of 17.36%. This margin reflects a modest improvement compared to the previous quarter, indicating some progress in cost management and operational efficiency. However, the year-on-year comparison shows a decline in growth rates for both sales and profit, suggesting that while the company is recovering from prior losses, it fac...

Read full news article

Bajaj Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-07-21 11:00:16

Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record quarterly net sales, the company’s overall financial trend has softened, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 June 2026.

Read full news article

Bajaj Healthcare Q1 FY27: Recovery Gains Momentum Despite Profitability Concerns

2026-07-21 09:47:52

Bajaj Healthcare Ltd., a Thane-based bulk drug manufacturer serving global pharmaceutical markets, reported a mixed performance for Q1 FY27 ending June 2026, with net profit rising to ₹13.89 crores—marking a sequential recovery of 171.54% from the previous quarter's loss of ₹19.41 crores. However, the year-on-year comparison reveals a modest 14.13% increase from ₹12.17 crores in Q1 FY26, whilst the stock has faced significant headwinds, declining 28.85% over the past year to close at ₹369.50 on July 21, 2026, with a market capitalisation of ₹1,243.84 crores.

Read full news article

Bajaj Healthcare Ltd is Rated Hold by MarketsMOJO

2026-07-12 10:10:37

Bajaj Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 July 2026, providing investors with the latest insights into its performance and outlook.